Ilya Gipp, MD, PhD, presented “Connected Care and Latest Developments in Prostate Cancer Management” during the 8th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2024.
How to cite: Gipp, Ilya. “Connected Care and Latest Developments in Prostate Cancer Management.” October 8, 2024. Accessed Jan 2025. https://grandroundsinurology.com/connected-care-and-latest-developments-in-prostate-cancer-management/
Connected Care and Latest Developments in Prostate Cancer Management – Summary
Ilya Gipp, MD, PhD, delivers a 9-minute presentation on connected care and advancements in prostate cancer management, emphasizing integrating innovative diagnostic and therapeutic approaches. Dr. Gipp discusses the pivotal role of MRI in prostate imaging, showcasing advancements in ultra-fast protocols that enhance efficiency without compromising diagnostic accuracy. He highlights targeted biopsy techniques enabled by data fusion, focal therapies, and the growing impact of theranostics, particularly radioligand therapies like PSMA PET, as transformative tools in treatment and monitoring.
A significant theme in Dr. Gipp’s presentation is integrating actionable data across departments, bridging radiology, urology, and oncology to foster precision care. He emphasizes the role of AI in utilizing these vast datasets for real-time decision-making and patient-specific treatment strategies. By demonstrating the value of connected care and data-driven innovation, his presentation provides essential insights for professionals aiming to advance prostate cancer management.
The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a unique multi-disciplinary forum organized to inform the key health care stakeholders about the emerging advances in clinical case and research and create a consensus-based vision for the future of precision care and educational and research strategy for its realization. The mission of the Summit is to fill the currently existing gap between the key experts of in vivo imaging, the world authorities in the in vitro fluid- and tissue-based molecular diagnostics, including genomics, and thought leaders in the development of novel observation strategies (e.g., active surveillance, or AS) and therapeutic interventions.
ABOUT THE AUTHOR
Dr. Gipp received his medical degree from the Russian State Medical University and his doctorate in neuroradiology from the Moscow State University of Medicine and Dentistry.
In his role as medical officer, he drives company strategy for oncology and supports marketing, research, and development teams. He is an oncology subject matter expert and has experience in executive sales, product and field marketing, and clinical science. Before joining Philips in 2005, Dr. Gipp was a practicing physician and chair of a large imaging department. He has over 50 publications in peer-reviewed journals related to diagnostic imaging, oncology, and healthcare management. Dr. Gipp is passionate about hybridization in clinical and technical fields and enabling delivery of personalized care.
